Application of proteomics in asthma research
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Choon-Sik | - |
dc.contributor.author | Rhim, Taiyoun | - |
dc.date.accessioned | 2021-08-12T05:45:48Z | - |
dc.date.available | 2021-08-12T05:45:48Z | - |
dc.date.issued | 2011-04 | - |
dc.identifier.issn | 1478-9450 | - |
dc.identifier.issn | 1744-8387 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/16629 | - |
dc.description.abstract | Bronchial asthma is caused by allergic airway inflammation, resulting in reversible airway obstruction, characterized by airway hyper-responsiveness, bronchoconstriction, increased mucus secretion and an increase in lung vessel permeability. The pathophysiological changes in asthma have been attributed to the altered expression of biologically plausible proteins associated with transcriptional pathways, inflammatory mediators, chemokines, cytokines, apoptosis and cell proliferation. Such multifactorial diseases characteristically involve an interplay of many genetic variations of molecular and biochemical pathways and their interactions with environmental factors. The complex nature of the asthma phenotype, together with genetic heterogeneity and environmental influences, has made it difficult to uncover the aspects that underlie this common disease. Recently, genomic and proteomic technologies have been developed to identify associations between genes, proteins and disease. This approach, called 'omics biology', aims to recognize early onset of disease, institute preventive treatment and identify new molecular targets for novel drugs in multifactorial diseases. This article reviews examples of how proteomic technology can be used to find asthma marker proteins (from the cell model to clinical samples). Identification of protein changes in different stages of asthma could provide further insights into the complex molecular mechanisms involved in this disease. These studies provide new insights for finding novel pathological mediators and biomarkers of asthma. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Future Drugs Ltd. | - |
dc.title | Application of proteomics in asthma research | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1586/EPR.11.4 | - |
dc.identifier.scopusid | 2-s2.0-79955066779 | - |
dc.identifier.wosid | 000289877400015 | - |
dc.identifier.bibliographicCitation | Expert Review of Proteomics, v.8, no.2, pp 221 - 230 | - |
dc.citation.title | Expert Review of Proteomics | - |
dc.citation.volume | 8 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 221 | - |
dc.citation.endPage | 230 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.subject.keywordPlus | LEUKOTRIENE-RECEPTOR ANTAGONIST | - |
dc.subject.keywordPlus | ASPIRIN-INDUCED ASTHMA | - |
dc.subject.keywordPlus | OBSTRUCTIVE PULMONARY-DISEASE | - |
dc.subject.keywordPlus | ALLERGIC AIRWAY INFLAMMATION | - |
dc.subject.keywordPlus | HUMAN BRONCHOALVEOLAR LAVAGE | - |
dc.subject.keywordPlus | EXHAUST PARTICLE CHEMICALS | - |
dc.subject.keywordPlus | GROUP-I ALLERGENS | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | MOUSE MODEL | - |
dc.subject.keywordPlus | BIOMARKER DISCOVERY | - |
dc.subject.keywordAuthor | asthma | - |
dc.subject.keywordAuthor | BAL fluid | - |
dc.subject.keywordAuthor | plasma | - |
dc.subject.keywordAuthor | proteomics | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.